Generated by GPT-5-mini| Children's Cancer and Leukaemia Group | |
|---|---|
| Name | Children's Cancer and Leukaemia Group |
| Abbreviation | CCLG |
| Formation | 20th century |
| Type | Charitable organisation |
| Region served | United Kingdom |
Children's Cancer and Leukaemia Group is a British charity and professional network dedicated to paediatric oncology and haematology. It brings together clinicians, researchers, nurses and allied health professionals to improve outcomes for children with cancer and leukaemia. The organisation collaborates with national health bodies, academic institutions and international partners to coordinate clinical care, trials and policy initiatives.
The organisation emerged from collaborations among clinicians at institutions such as Great Ormond Street Hospital, Royal Marsden Hospital, Addenbrooke's Hospital, Bristol Royal Hospital for Children and Alder Hey Children's Hospital. Early meetings involved specialists from Institute of Child Health, University College London, University of Oxford, University of Cambridge and King's College London and drew on frameworks used by groups including Children's Oncology Group, European Society for Paediatric Oncology, International Society of Paediatric Oncology and historic programmes at Royal Hospital for Sick Children, Edinburgh. National initiatives linked to National Health Service (United Kingdom), Scottish Government, Welsh Government and Northern Ireland Health and Social Care influenced structural development. Notable clinical figures connected by historical conferences included consultants trained at University of Glasgow, Imperial College London and Newcastle University who had previously worked with teams from St Bartholomew's Hospital and Leeds General Infirmary.
The group's governance model reflects practices found at NHS England, Health and Social Care Department (Northern Ireland), National Institute for Health and Care Excellence and international standards from World Health Organization. The board typically includes representatives from professional bodies such as Royal College of Paediatrics and Child Health, Royal College of Nursing, Royal College of Pathologists and academic chairs from University of Southampton, University of Manchester and Queen Mary University of London. Strategic planning has aligned with policies promoted by Department of Health and Social Care (United Kingdom), Medical Research Council (United Kingdom), Wellcome Trust and regulatory frameworks like ClinicalTrials.gov registration norms. Advisory input has come from patient groups modelled on organisations like Macmillan Cancer Support and Cancer Research UK.
Collaborative trials have been run with partners such as Cancer Research UK, Medical Research Council (United Kingdom), European Medicines Agency, National Institute for Health and Care Research and university clinical research units at University of Edinburgh, University of Birmingham and University of Leeds. Investigators have published findings in journals associated with The Lancet, British Medical Journal, Nature Medicine, Journal of Clinical Oncology and Blood (journal). Trial networks have interfaced with international consortia like Pediatric Oncology Group and regulatory bodies including Medicines and Healthcare products Regulatory Agency. Methodological exchange occurred with groups at Dana–Farber Cancer Institute, St Jude Children's Research Hospital, Fred Hutchinson Cancer Center and Institut Curie.
Clinical standards have been informed by multidisciplinary teams drawing on expertise from Great Ormond Street Hospital, King's College Hospital, Royal Liverpool Children's Hospital, Birmingham Children's Hospital and Royal Victoria Infirmary. Psychosocial support models reference practices from Young Lives vs Cancer, Sands (Stillbirth and neonatal death charity), Leonard Cheshire Disability and peer-support initiatives linked to Marie Curie (charity). Palliative care coordination has been aligned with services at Child Bereavement UK, and rehabilitation pathways have drawn on links with British Red Cross and community health partnerships coordinated with local health trusts across England, Scotland, Wales and Northern Ireland.
Professional development programmes have been delivered in collaboration with bodies such as Royal College of Paediatrics and Child Health, Royal College of Nursing, General Medical Council, Health Education England and academic departments at University of Glasgow, Cardiff University and University of Nottingham. Training courses for nurses, doctors and allied professionals often reference curricula used by European School of Oncology and exchange placements have occurred with centres including Great Ormond Street Hospital, St Jude Children's Research Hospital and Bambino Gesù Hospital. Conferences and symposia have been hosted alongside groups such as British Paediatric Oncology Group, European Society for Paediatric Oncology and International Society of Paediatric Oncology.
Funding sources have included grants and partnerships with Cancer Research UK, Wellcome Trust, National Institute for Health and Care Research, Medical Research Council (United Kingdom), philanthropic foundations like Gatsby Charitable Foundation and corporate sponsors including pharmaceutical companies operating under Association of the British Pharmaceutical Industry guidelines. Strategic partnerships have been formed with academic institutions such as University of Oxford, University College London, King's College London and international collaborators at Harvard Medical School, University of Toronto and University of Melbourne.
Advocacy work has interfaced with policy agencies including Department of Health and Social Care (United Kingdom), National Institute for Health and Care Excellence and parliamentary groups such as the All-Party Parliamentary Group on Cancer. Public awareness campaigns paralleled initiatives by Macmillan Cancer Support, Cancer Research UK and Children in Need. Measurable impacts include contributions to survival-improvement publications in outlets like The Lancet Oncology and British Medical Journal, influence on national guidelines produced with NHS England and enhanced clinical pathways adopted across paediatric centres including Great Ormond Street Hospital and Royal Marsden Hospital.
Category:Medical and health organisations based in the United Kingdom